Global Excoriation (Skin-picking) Disorder Market, By Treatment (Antidepressants, Anticonvulsants, Antipsychotics, Cognitive-behavioural Therapy (CBT), Others), Diagnosis (Physical Examination, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
Excoriation (Skin-picking) Disorder Market Analysis and Size
Excoriation disorder is an obsessive-compulsive disorder-like mental disease. It is defined as picking at one's own skin over and over again, resulting in skin sores and causing severe disruption in one's life. Picking at healthy skin, small skin abnormalities, lesions, or scabs is a common occurrence. This is a chronic condition, with periods of remission interspersed with times of increased symptom intensity. This neurological disorder can produce severe distress and impairment in various areas of functioning, including social avoidance. Excoriation disorder is also called chronic skin-picking or dermatillomania.
The rise in excoriation (skin-picking) disorder and rising healthcare expenditure are the major factors influencing the market growth rate. Furthermore, advancements in medical technology, growing government funding, and rising initiatives by public and private organizations to spread awareness about the disease and its available treatment options are the factors that will expand the excoriation (skin-picking) disorder market. Likewise, growing incidences of stress, depression, and anxiety, changing lifestyles, and the dearth of physical exercise will cushion the market growth rate.
Data Bridge Market Research analyses that the global excoriation (skin-picking) disorder market which was USD 657.58 million in 2022, would rocket up to USD 1,027.25 million by 2030, and is expected to undergo a CAGR of 5.8% during the forecast period. “Physical examination” dominates the diagnosis segment of the global excoriation (skin-picking) disorder market owing to rise in the aging population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Excoriation (Skin-picking) Disorder Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Antidepressants, Anticonvulsants, Antipsychotics, Cognitive-behavioral Therapy (CBT), Others), Diagnosis (Physical Examination, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), AstraZeneca (U.S.), Johnson & Johnson Private Limited (U.S.), Bristol-Myers Squibb Company (U.S.), Sandoz International GmbH (Germany), Apotex Inc. (Canada), Mylan N.V. (Netherlands), H. Lundbeck A/S (Denmark), Allergan (Ireland), Sanofi (France), Merck Sharp & Dohme Corp. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Alkermes (Ireland), Takeda Pharmaceutical Company Limited (Japan), OPKO Health, Inc. (U.S.), Intra-Cellular Therapies Inc. (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Lupin (India), Novartis AG (Switzerland), Bausch Health Companies Inc. (Canada), Eli Lilly and Company (U.S.), Sumitomo Dainippon Pharma Co., Ltd. (Japan), AbbVie Inc. (U.S.), and Dr. Reddy’s Laboratories Ltd. (India)
|
|
Market Opportunities
|
|
Market Definition
Excoriation disorder is an obsessive-compulsive disorder such as mental disease. It is defined by picking at one's own skin over and over again, resulting in skin sores and causing severe disruption in one's life. Picking at healthy skin, small skin abnormalities, lesions, or scabs is a common occurrence. This is a chronic condition, with periods of remission interspersed with times of increased symptom intensity. This neurological disorder can produce severe distress and impairment in various areas of functioning, including social avoidance. Excoriation disorder is also called chronic skin-picking or dermatillomania.
Global Excoriation (Skin-picking) Disorder Market Dynamics
Drivers
- Growing Awareness and Diagnosis
Increased awareness of mental health issues, including Excoriation Disorder, has led to more individuals seeking help and receiving a formal diagnosis. Greater recognition of the disorder has expanded the potential market for treatments and services.
- Psychological and Behavioral Therapies
Cognitive-Behavioral Therapy (CBT) and related therapies have shown promise in treating excoriation disorder. The availability and accessibility of these evidence-based therapies contribute to market growth.
Opportunities
- Telehealth and Digital Therapeutics
The rise of telehealth and digital therapeutic solutions in mental healthcare presents opportunities for reaching individuals with excoriation disorder, especially those who may have limited access to in-person treatment. Virtual therapy and digital interventions can provide support and treatment options.
Restraint/Challenge
- Limited Treatment Options
While therapies such as CBT have shown promise, there is still a lack of specific pharmacological treatments approved for Excoriation Disorder. This limits the range of treatment options available.
This global excoriation (skin-picking) disorder market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global excoriation (skin-picking) disorder market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Excoriation (Skin-Picking) Disorder Market Scope
Global excoriation (skin-picking) disorder market is categorized into six notable segments which are based on the treatment, diagnosis, dosage, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Antidepressants
- Anticonvulsants
- Antipsychotics
- Cognitive-Behavioral Therapy (cbt)
- Others
Diagnosis
- Physical Examination
- Others
Dosage
- Tablet
- Injection
- Others
Route of Administration
- Oral
- Intravenous
- Others
End-Users
- Clinic
- Hospital
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Excoriation (Skin-Picking) Disorder Market Regional Analysis/Insights
Global excoriation (skin-picking) disorder market is analyzed and market size information is provided by the treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the excoriation (skin-picking) disorder market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the excoriation (skin-picking) disorder market due to major key players, high healthcare expenditure and well-developed healthcare infrastructure in this region.
Asia-Pacific is expected to grow during the forecast period of 2023 to 2030 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Excoriation (Skin-Picking) Disorder Market Share Analysis
Excoriation (skin-picking) disorder market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to excoriation (skin-picking) disorder market research.
Some of the major players operating in the global excoriation (skin-picking) disorder market are:
- GlaxoSmithKline plc (U.K.)
- Pfizer Inc. (U.S.)
- AstraZeneca (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Sandoz International GmbH (Germany)
- Apotex Inc. (Canada)
- Mylan N.V. (U.S.)
- H. Lundbeck A/S (Denmark)
- Allergan (Ireland)
- Sanofi (France)
- Merck Sharp & Dohme Corp. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Alkermes (Ireland)
- Takeda Pharmaceutical Company Limited (Japan)
- OPKO Health, Inc. (U.S.)
- Intra-Cellular Therapies Inc. (U.S.)
- Janssen Pharmaceuticals, Inc. (U.S.)
- Lupin (India)
- Novartis AG (Switzerland)
- Bausch Health Companies Inc. (Canada)
- Eli Lilly and Company (U.S.)
- Sumitomo Dainippon Pharma Co., Ltd. (Japan)
- AbbVie Inc. (U.S.)
- Dr. Reddy’s Laboratories Ltd. (India)
SKU-